Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Viral”

1,037 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,037 results

Early research (Phase 1)Study completedNCT01689285
What this trial is testing

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir

Who this might be right for
Varicella Zoster Virus InfectionHerpes Simplex Virus Infection
Radboud University Medical Center 16
Early research (Phase 1)Study completedNCT01017185
What this trial is testing

Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions

Who this might be right for
Refractory Head and Neck CancerSquamous Cell Carcinoma, SkinCarcinoma of the Breast+1 more
Takara Bio Inc. 28
Not applicableStudy completedNCT00822276
What this trial is testing

The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)

Who this might be right for
Methicillin-Resistant Staphylococcus AureusAtopic DermatitisEczema Herpeticum+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT04407559
What this trial is testing

COVID-SErology in Rheumatoid Arthritis (COVID-19)

Who this might be right for
COVID-19Rheumatoid Arthritis
University Hospital, Montpellier 216
Post-approval studies (Phase 4)Study completedNCT00006190
What this trial is testing

Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Looking for participantsNCT04305691
What this trial is testing

Trial of Ixazomib for Kaposi Sarcoma

Who this might be right for
Kaposi SarcomaSkin
AIDS Malignancy Consortium 41
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Testing effectiveness (Phase 2)WithdrawnNCT01610765
What this trial is testing

A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)

Who this might be right for
Herpes Simplex Virus
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Study completedNCT00130286
What this trial is testing

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Who this might be right for
HIV-Associated Lipodystrophy SyndromeInsulin ResistanceHIV Infections+2 more
Weill Medical College of Cornell University 77
Testing effectiveness (Phase 2)Study completedNCT03017846
What this trial is testing

Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2

Who this might be right for
Molluscum Contagiosum
Steven R Cohen 30
Not applicableLooking for participantsNCT05284877
What this trial is testing

The Organ Transplant Recipient HPV and Skin Cancer Study

Who this might be right for
Solid Organ Transplant RecipientSkin CancerSkin Dysplasia+4 more
Merete Haedersdal 1,500
Testing effectiveness (Phase 2)Study completedNCT01072734
What this trial is testing

Auto-immunity in Lupus Patients After Influenza Vaccine

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 28
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Load More Results